ISOSORBIDE DINITRATE AND HYDRALAZINE HYDROCHLORIDE Drug Patent Profile
✉ Email this page to a colleague
When do Isosorbide Dinitrate And Hydralazine Hydrochloride patents expire, and what generic alternatives are available?
Isosorbide Dinitrate And Hydralazine Hydrochloride is a drug marketed by I3 Pharms and Riconpharma Llc and is included in two NDAs.
The generic ingredient in ISOSORBIDE DINITRATE AND HYDRALAZINE HYDROCHLORIDE is hydralazine hydrochloride; isosorbide dinitrate. There are twenty-one drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the hydralazine hydrochloride; isosorbide dinitrate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ISOSORBIDE DINITRATE AND HYDRALAZINE HYDROCHLORIDE?
- What are the global sales for ISOSORBIDE DINITRATE AND HYDRALAZINE HYDROCHLORIDE?
- What is Average Wholesale Price for ISOSORBIDE DINITRATE AND HYDRALAZINE HYDROCHLORIDE?
Summary for ISOSORBIDE DINITRATE AND HYDRALAZINE HYDROCHLORIDE
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 2 |
Finished Product Suppliers / Packagers: | 3 |
Clinical Trials: | 7 |
Formulation / Manufacturing: | see details |
What excipients (inactive ingredients) are in ISOSORBIDE DINITRATE AND HYDRALAZINE HYDROCHLORIDE? | ISOSORBIDE DINITRATE AND HYDRALAZINE HYDROCHLORIDE excipients list |
DailyMed Link: | ISOSORBIDE DINITRATE AND HYDRALAZINE HYDROCHLORIDE at DailyMed |
![ISOSORBIDE DINITRATE AND HYDRALAZINE HYDROCHLORIDE drug patent expirations Drug patent expirations by year for ISOSORBIDE DINITRATE AND HYDRALAZINE HYDROCHLORIDE](/p/graph/s/t/ISOSORBIDE_DINITRATE_AND_HYDRALAZINE_HYDROCHLORIDE-patent-expirations.png)
Recent Clinical Trials for ISOSORBIDE DINITRATE AND HYDRALAZINE HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Danish Council for Independent Research | Phase 4 |
Henrik Wiggers | Phase 4 |
The Aase og Ejnar Danielsen Foundation | Phase 4 |
See all ISOSORBIDE DINITRATE AND HYDRALAZINE HYDROCHLORIDE clinical trials
Pharmacology for ISOSORBIDE DINITRATE AND HYDRALAZINE HYDROCHLORIDE
Drug Class | Arteriolar Vasodilator Nitrate Vasodilator |
Physiological Effect | Arteriolar Vasodilation Vasodilation |
US Patents and Regulatory Information for ISOSORBIDE DINITRATE AND HYDRALAZINE HYDROCHLORIDE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
I3 Pharms | ISOSORBIDE DINITRATE AND HYDRALAZINE HYDROCHLORIDE | hydralazine hydrochloride; isosorbide dinitrate | TABLET;ORAL | 215988-001 | Jan 17, 2024 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Riconpharma Llc | ISOSORBIDE DINITRATE AND HYDRALAZINE HYDROCHLORIDE | hydralazine hydrochloride; isosorbide dinitrate | TABLET;ORAL | 215586-001 | Apr 6, 2022 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |